GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors
Direct targeting of mutant KRas is challenging and alternative approaches are needed. Here they show glycogen synthase kinase 3 (GSK3) to be required for the growth and survival of human mutant KRas-dependent tumors but dispensable for mutant KRas-independent tumors and show GSK3 inhibition to inhib...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2018
|
| Subjects: | |
| Online Access: | https://doaj.org/article/e4dd4e549d124d48b1ca42f85db738ff |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|